中医药临床杂志2024,Vol.36Issue(11) :2223-2228.DOI:10.16448/j.cjtcm.2024.1140

支气管哮喘发病机制相关细胞信号通路的研究进展

Research Progress on Cellular Signaling Pathways Related to the Pathogenesis of Bronchial Asthma

罗红英 李强 刘海萍 刘莉 朱俊俊 许发功 晋文蔓
中医药临床杂志2024,Vol.36Issue(11) :2223-2228.DOI:10.16448/j.cjtcm.2024.1140

支气管哮喘发病机制相关细胞信号通路的研究进展

Research Progress on Cellular Signaling Pathways Related to the Pathogenesis of Bronchial Asthma

罗红英 1李强 1刘海萍 1刘莉 1朱俊俊 2许发功 1晋文蔓3
扫码查看

作者信息

  • 1. 青海省中医院 青海 西宁 810000
  • 2. 青海大学 青海 西宁 810016
  • 3. 天津中医药大学第一附属医院 天津 300381
  • 折叠

摘要

哮喘(bronchial asthma,BA)是一种复杂的慢性气道炎症性疾病,其特征为气道高反应、嗜酸性粒细胞浸润、可逆性气流阻塞、气道重塑、粘液分泌过多和杯状细胞增生.通常表现为喘息、咳嗽和呼吸困难.近年来,信号通路的靶向治疗已显示出作为治疗该疾病的新策略.文章将从参与哮喘发病机制密切相关的细胞信号通路进行系统综述,以期为临床防治哮喘提供参考.

Abstract

Bronchial asthma(BA)is a complex chronic inflammatory disease of the airways,characterized by air-way hyperresponsiveness,eosinophil infiltration,reversible airflow obstruction,airway remodeling,excessive mucus secretion,and goblet cell proliferation.Usually manifested as wheezing,coughing,and difficulty breathing.In recent years,targeted therapy of signaling pathways has been shown as a new strategy for treating this disease.This article will provide a systematic review of cell signaling pathways closely related to the pathogenesis of asthma,with the aim of providing potential targets for the clinical development of new drugs for the treatment of asthma.

关键词

哮喘/发病机制/信号通路/综述

Key words

asthma/signaling pathways/pathogenesis/review

引用本文复制引用

出版年

2024
中医药临床杂志
中华中医药学会

中医药临床杂志

影响因子:0.636
ISSN:1672-7134
段落导航相关论文